LISATA THERAPEUTICS, INC. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Lisata Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q2 2024.
  • Lisata Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 8.32M shares, a 2.32% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 8.32M +189K +2.32% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 8.31M +309K +3.86% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 8.15M +284K +3.61% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 8.14M +277K +3.52% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 8.13M -52.5M -86.6% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 8M -52.5M -86.8% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 7.87M +3.88M +97.3% Dec 31, 2022 10-K 2024-02-29
Q3 2022 7.86M -51.9M -86.8% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 60.6M +1.07M +1.79% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 60.5M +1.03M +1.74% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 3.99M -15.4M -79.4% Dec 31, 2021 10-K 2023-03-30
Q3 2021 59.8M +40.4M +208% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 59.5M +43.9M +282% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 59.5M +48.9M +459% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 19.4M +8.86M +84.2% Dec 31, 2020 10-K 2022-03-22
Q3 2020 19.4M +9M +86.4% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 15.6M +5.17M +49.7% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 10.6M +245K +2.36% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 10.5M +652K +6.61% Dec 31, 2019 10-K 2021-02-25
Q3 2019 10.4M +558K +5.66% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 10.4M +677K +6.96% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 10.4M +819K +8.55% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 9.87M +382K +4.03% Dec 31, 2018 10-K 2020-03-05
Q3 2018 9.85M +426K +4.52% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 9.74M +823K +9.23% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 9.57M +621K +6.94% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 9.48M +1.28M +15.6% Dec 31, 2017 10-K 2019-03-14
Q3 2017 9.43M +1.25M +15.2% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 8.91M +2.99M +50.4% Jun 30, 2017 10-Q 2017-08-10
Q1 2017 8.95M -50.2M -84.9% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 8.21M +2.53M +44.6% Dec 31, 2016 10-K 2018-03-22
Q3 2016 8.18M -47.3M -85.3% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 5.93M -49.5M -89.3% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 59.1M +19.7M +50% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 5.67M -31.1M -84.6% Dec 31, 2015 10-Q 2016-11-07
Q3 2015 55.5M +20M +56.4% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 55.5M +20.5M +58.7% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 39.4M +10.8M +37.9% Mar 31, 2015 10-Q 2015-05-06
Q4 2014 36.8M +9.59M +35.3% Dec 31, 2014 10-Q 2015-11-05
Q3 2014 35.5M +14.3M +67.4% Sep 30, 2014 10-Q 2014-10-30
Q2 2014 34.9M +15.4M +78.4% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 28.6M -142M -83.2% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 27.2M +10.8M +66.1% Dec 31, 2013 10-Q 2014-10-30
Q3 2013 21.2M -134M -86.3% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 19.6M -118M -85.8% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 170M +40.4M +31.1% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 16.4M -93M -85% Dec 31, 2012 10-K 2014-03-13
Q3 2012 155M +54.8M +54.6% Sep 30, 2012 10-Q 2012-11-13
Q2 2012 138M +55.4M +67.3% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 130M Mar 31, 2012 10-Q 2012-05-11
Q4 2011 109M +45.1M +70.2% Dec 31, 2011 10-K 2013-03-11
Q3 2011 100M Sep 30, 2011 10-Q 2011-11-10
Q2 2011 82.2M Jun 30, 2011 10-Q 2011-08-12
Q4 2010 64.2M Dec 31, 2010 8-K 2012-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.